Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole/Vonoprazan Dual Therapy for H. pylori
NCT06250634Completed
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Feb 2024
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of vonoprazan and esomeprazole in Helicobacter pylori infection (4 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Helicobacter pylori eradication rate. Started Feb 2024; status: completed.
02
Drugs
vonoprazanesomeprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06250634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06250634.